Plain-English translation of NCT07610473 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called to see if it can help people with depression who are already taking other antidepressant medications but haven't gotten enough relief. About 118 people will participate, and half will receive the medication while the other half receives a placebo (a dummy pill). The study will last 8 weeks and will measure whether the medication helps reduce depression symptoms and how safe it is.
Many people with depression continue to struggle with symptoms even while taking antidepressant medications. This trial aims to see if this medication could be an add-on treatment that makes existing depression treatments work better.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would visit the study site multiple times over 8 weeks. At the beginning, you'll have physical and neurological exams, blood and urine tests, and interviews to confirm you're eligible. Then you'll be randomly assigned to take either the medication or a placebo along with your regular depression medication. Throughout the 8 weeks, you'll have regular check-ins with blood tests and assessments to track how you're doing and how the medication is working in your body.
AI-generated summary from trial data ยท Oct 3, 2026 ยท Not medical advice
United States